Sage Therapeutics, Inc. (SAGE): Price and Financial Metrics
SAGE Price/Volume Stats
| Current price | $4.91 | 52-week high | $28.26 |
| Prev. close | $4.91 | 52-week low | $4.62 |
| Day low | $4.62 | Volume | 1,586,300 |
| Day high | $5.13 | Avg. volume | 968,801 |
| 50-day MA | $6.80 | Dividend yield | N/A |
| 200-day MA | $12.06 | Market Cap | 300.36M |
SAGE Stock Price Chart Interactive Chart >
Sage Therapeutics, Inc. (SAGE) Company Bio
Sage Therapeutics is a clinical-stage biopharmaceutical company committed to developing and commercializing novel medicines to treat life-threatening, rare central nervous system, or CNS, disorders. The company was founded in 2010 and is based in Cambridge, Massachusetts.
SAGE Price Returns
| 1-mo | -35.82% |
| 3-mo | -41.62% |
| 6-mo | -58.32% |
| 1-year | -74.73% |
| 3-year | -87.70% |
| 5-year | -96.70% |
| YTD | -77.34% |
| 2023 | -43.18% |
| 2022 | -10.34% |
| 2021 | -50.83% |
| 2020 | 19.84% |
| 2019 | -24.64% |
Continue Researching SAGE
Here are a few links from around the web to help you further your research on Sage Therapeutics Inc's stock as an investment opportunity:Sage Therapeutics Inc (SAGE) Stock Price | Nasdaq
Sage Therapeutics Inc (SAGE) Stock Quote, History and News - Yahoo Finance
Sage Therapeutics Inc (SAGE) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...